LRMR
Larimar Therapeutics, Inc. · Healthcare
* Director by Deputization, 10% James E Flynn bought $35.0M of Larimar Therapeutics, Inc.
Bought$34,999,990
$3.15Price
11,111,108Shares
+191%Stake
What LRMR did for a copier
- $1,000 copied at Wed, Sep 21 open, $3.44
- $898
- S&P 500, same days
- −2.9%
Measured over 30 trading days, to the Nov 2 close.
James E Flynn's record
8 other buys with 3 months of prices since 2016: on average −22.9% against the S&P 500, and 1 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 16. Filed Tue, Sep 20, 8:31 PM ET, after the close. Returns use the Sep 21 open and the Nov 2 close. Not investment advice.